A prospective, randomized, comparative trial evaluating respiratory depression during patient-controlled versus anesthesiologist-administered propofol-remifentanil sedation for elective colonoscopy
To access this article, please choose from the options below
DISCLOSURE: The following authors disclosed financial relationships relevant to this publication: J.E. Mandel: Speaker for Bioniche Pharma. G.R. Lichtenstein: Advisory committee and lecture funding: Consultant: Abbott Laboratories. M.L. Kochman: Spouse: stock and executive: Merck.
PII: S0016-5107(10)00045-3
doi:10.1016/j.gie.2010.01.031
© 2010 American Society for Gastrointestinal Endoscopy. Published by Elsevier Inc. All rights reserved.
